ChAdOx1 COVID vaccines express RBD open prefusion SARS-CoV-2 spikes on the cell surface
Preprint
Zhang P. et al, (2023)
Statement in Support of: "Virology under the Microscope-a Call for Rational Discourse".
Journal article
Speck P. et al, (2023), mSphere
Statement in Support of: "Virology under the Microscope-a Call for Rational Discourse".
Journal article
Speck P. et al, (2023), J Virol
Statement in Support of: "Virology under the Microscope-a Call for Rational Discourse".
Journal article
Speck P. et al, (2023), mBio
Adenoviral vectored vaccination protects against Crimean-Congo Haemorrhagic Fever disease in a lethal challenge model.
Journal article
Saunders JE. et al, (2023), EBioMedicine, 90
ChAdOx1 nCoV-19 vaccination generates spike-specific CD8+ T cells in aged mice.
Journal article
Foster WS. et al, (2023), Immunol Cell Biol
Tfh cells and the germinal center are required for memory B cell formation & humoral immunity after ChAdOx1 nCoV-19 vaccination.
Journal article
Foster WS. et al, (2022), Cell Rep Med
STING-pathway modulation to enhance the immunogenicity of adenoviral-vectored vaccines.
Journal article
Padron-Regalado E. et al, (2022), Sci Rep, 12
ChAdOx1 nCoV-19 (AZD1222) or nCoV-19-Beta (AZD2816) protect Syrian hamsters against Beta Delta and Omicron variants.
Journal article
van Doremalen N. et al, (2022), Nat Commun, 13
Detection and quantification of antibody to SARS CoV 2 receptor binding domain provides enhanced sensitivity, specificity and utility.
Journal article
Rosadas C. et al, (2022), J Virol Methods, 302
The ChAdOx1 vectored vaccine, AZD2816, induces strong immunogenicity against SARS-CoV-2 beta (B.1.351) and other variants of concern in preclinical studies.
Journal article
Spencer AJ. et al, (2022), EBioMedicine, 77
Deep immune phenotyping and single-cell transcriptomics allow identification of circulating TRM-like cells which correlate with liver-stage immunity and vaccine-induced protection from malaria
Journal article
EWER K., (2022), Frontiers in Immunology
Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002)
Journal article
EWER K. et al, (2021), The Lancet
Ultra-low dose immunization and multi-component vaccination strategies enhance protection against malaria in mice.
Journal article
Collins KA. et al, (2021), Sci Rep, 11
Author Correction: T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial.
Journal article
Barrett JR. et al, (2021), Nature medicine
Author Correction: Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses.
Journal article
Barrett JR. et al, (2021), Nature medicine
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.
Journal article
Voysey M. et al, (2021), Lancet, 397, 881 - 891
T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a Phase 1/2 clinical trial.
Journal article
LAMBE T. et al, (2020), Nature Medicine
Antigen-specific competitive inhibition of CD4+ T cell recruitment into the primary immune response
Preprint
Spencer AJ. et al, (2020)
ChAdOx1 nCoV-19 vaccination prevents SARS-CoV-2 pneumonia in rhesus macaques.
Working paper
van Doremalen N. et al, (2020), bioRxiv : the preprint server for biology